PBIT是一种特异性抑制Jumonji AT-rich Interactive Domain 1 (JARID1)酶的抑制剂。PBIT通过约3 μM的IC50值抑制JARID1B(KDM5B或PLU1)组蛋白去甲基化酶。PBIT还抑制JARID1A和JARID1C,IC50分别为6 μM和4.9 μM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | KDM1 ↓ ↑ | KDM2 ↓ ↑ | KDM3 ↓ ↑ | KDM4 ↓ ↑ | KDM5 ↓ ↑ | KDM6 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OG-L002 |
+++
LSD1, IC50: 20 nM |
99%+ | |||||||||||||||||
| ORY-1001 |
+++
LSD1, IC50: 20 nM |
98% | |||||||||||||||||
| SP-2509 |
++++
LSD1, IC50: 13 nM |
98+% | |||||||||||||||||
| GSK2879552 2HCl |
+
LSD1, Ki: 1.7 μM |
99%+ | |||||||||||||||||
| T-3775440 HCl |
++++
LSD1, IC50: 2.1 nM |
99% | |||||||||||||||||
| GSK-LSD1 2HCl |
+++
LSD1, IC50: 16 nM |
98% | |||||||||||||||||
| Pulrodemstat benzenesulfonate | ✔ | 99%+ | |||||||||||||||||
| IOX1 |
+
KDM2A, IC50: 1.8 μM |
+++
KDM3A, IC50: 0.1 μM |
++
KDM4E, IC50: 2.3 μM KDM4C, IC50: 0.6 μM |
+
KDM5C, IC50: 19 μM |
+
KDM6B, IC50: 1.6 μM |
99% | |||||||||||||
| PFI-90 | ✔ | 99%+ | |||||||||||||||||
| ML324 |
+
JMJD2, IC50: 920 nM |
99%+ | |||||||||||||||||
| NCGC00244536 |
++++
KDM4, IC50: 10 nM |
99% | |||||||||||||||||
| KDM4D-IN-1 |
++
KDM4D, IC50: 0.41 μM |
99%+ | |||||||||||||||||
| GSK467 |
++++
KDM5B, Ki: 10 nM |
99% | |||||||||||||||||
| GSK-J1 |
+++
JMJD3, IC50: 60 nM |
99%+ | |||||||||||||||||
| (Z)-JIB-04 |
++
JMJD2E, IC50: 340 nM JMJD2A, IC50: 1100 nM |
++
JARID1A, IC50: 230 nM |
++
JMJD3, IC50: 855 nM |
97% | |||||||||||||||
| CPI-455 |
++++
KDM5A, IC50: 10 nM |
++++
KDM5, IC50: 10 nM |
98% | ||||||||||||||||
| JIB-04 |
++
JMJD2E, IC50: 435 nM JMJD2D, IC50: 290 nM |
++
JARID1A, IC50: 230 nM |
++
JMJD3, IC50: 855 nM |
98% | |||||||||||||||
| GSK-J4 HCl |
+++
JMJD3, IC50: 60 nM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | PBIT is a specific inhibitor of JARID1. It inhibits the histone demethylase activity of JARID1B (also known as KDM5B or PLU1), with an IC50 of approximately 3 μM. PBIT also inhibits JARID1A and JARID1C, with IC50 values of 6 μM and 4.9 μM, respectively. PBIT suppresses the proliferation of cells expressing high levels of JARID1B. The inhibition of cell proliferation by PBIT is dependent on the level of JARID1B, specifically at concentrations of 1-10 μM in UACC-812 cells and 2.5-10 μM in MCF7 and MCF10A cells over a period of 72 hours[1]. |
| Concentration | Treated Time | Description | References | |
| HeLa cells | 10 or 30 µM | 24 hours | PBIT treatment prevented the JARID1B overexpression-induced decrease of H3K4me3. | J Biol Chem. 2013 Mar 29;288(13):9408-17 |
| RWPE-1 cells | 1–20 µM | 72 hours | To assess the effect of PBIT on the proliferation of RWPE-1 cells, results showed that PBIT significantly decreased the viability of RWPE-1 cells. | Exp Cell Res. 2024 Apr 1;437(1):113991 |
| LNCaP-MDV3100 cells | 1–20 µM | 72 hours | To assess the effect of PBIT on the proliferation of LNCaP-MDV3100 cells, results showed that PBIT significantly decreased the viability of LNCaP-MDV3100 cells. | Exp Cell Res. 2024 Apr 1;437(1):113991 |
| PC-3 cells | 1–20 µM | 72 hours | To assess the effect of PBIT on the proliferation of PC-3 cells, results showed that PBIT significantly decreased the viability of PC-3 cells. | Exp Cell Res. 2024 Apr 1;437(1):113991 |
| C4–2B cells | 1–20 µM | 72 hours | To assess the effect of PBIT on the proliferation of C4–2B cells, results showed that PBIT significantly decreased the viability of C4–2B cells. | Exp Cell Res. 2024 Apr 1;437(1):113991 |
| LNCaP cells | 1–20 µM | 72 hours | To assess the effect of PBIT on the proliferation of LNCaP cells, results showed that PBIT significantly decreased the viability of LNCaP cells. | Exp Cell Res. 2024 Apr 1;437(1):113991 |
| UACC-812 cells | 10 µM | 72 hours | PBIT treatment significantly inhibited the proliferation of UACC-812 cells. | J Biol Chem. 2013 Mar 29;288(13):9408-17 |
| MCF7 cells | 10 µM | 72 hours | PBIT treatment significantly increased global levels of H3K4me3. | J Biol Chem. 2013 Mar 29;288(13):9408-17 |
| Administration | Dosage | Frequency | Description | References | ||
| Male F344 rats | NMBA-induced esophageal squamous cell carcinoma model | Dietary administration | 50 ppm | Freshly prepared weekly, lasting for 35 weeks | To evaluate the preventive effect of PBIT combined with celecoxib on NMBA-induced esophageal tumors, results showed that the combination significantly reduced tumor incidence and multiplicity. | J Funct Foods. 2016 Dec;27:84-94 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.14mL 0.83mL 0.41mL |
20.72mL 4.14mL 2.07mL |
41.44mL 8.29mL 4.14mL |
|
| CAS号 | 2514-30-9 |
| 分子式 | C14H11NOS |
| 分子量 | 241.31 |
| SMILES Code | O=C1N(C2=CC=C(C)C=C2)SC3=C1C=CC=C3 |
| MDL No. | MFCD05856231 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | KRXMYBAZKJBJAB-UHFFFAOYSA-N |
| Pubchem ID | 935415 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,Store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(207.2 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1